TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Palette Life Sciences AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
61,063
|
358,351
|
189,773 |
| Financial expenses |
39,556
|
40,397
|
13,764 |
| Earnings before taxes |
-341,413
|
-325,438
|
-225,641 |
| EBITDA |
-335,661
|
-283,121
|
-210,125 |
| Total assets |
880,368
|
374,211
|
193,390 |
| Current assets |
77,757
|
257,496
|
184,436 |
| Current liabilities |
453,213
|
239,402
|
44,812 |
| Equity capital |
427,155
|
-141,901
|
55,536 |
| - share capital |
3,088
|
3,088
|
2,693 |
| Employees (average) |
2
|
84
|
49 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
48.5%
|
-37.9%
|
28.7% |
| Turnover per employee |
30,532
|
4,266
|
3,873 |
| Profit as a percentage of turnover |
-559.1%
|
-90.8%
|
-118.9% |
| Return on assets (ROA) |
-34.3%
|
-76.2%
|
-109.6% |
| Current ratio |
17.2%
|
107.6%
|
411.6% |
| Return on equity (ROE) |
-79.9%
|
229.3%
|
-406.3% |
| Change turnover | |||
| Change turnover % | 89% | ||
| Chg. No. of employees | |||
| Chg. No. of employees % | 71% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.